Evaluation of safety and efficacy of inhibitor of phosphodiesterase 5 to patients with dystrophinopathy
Not Applicable
- Conditions
- patients with dystrophinopathy
- Registration Number
- JPRN-UMIN000032431
- Lead Sponsor
- ational Hospital Organization Toneyama National Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
patients with 24-hour mechanical ventilation (not include night NPPV) hypertension(Sys>135mmHg or Diast>90mmHg) heart failure with BNP>100pg/ml or LVEF<50% arrhythmia (Af,AF, VT,PSVT) diabetus mellitus
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method